Jia Cao

Direktor/Vorstandsmitglied bei Beijing Tri Prime Gene Pharmaceutical Co., Ltd.

40 Jahre

Health Technology

Profil

Jia Cao has worked as a Member-Supervisory Board & Director-HR at Beijing Tri Prime Gene Pharmaceutical Co., Ltd.
since 2014.

Unternehmen	Position	Beginn
Beijing Tri Prime Gene Pharmaceutical Co., Ltd. Beijing Tri Prime Gene Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Tri Prime Gene Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of biomedicine. Its key products include human interferon a1b for injection, human interferon a1b injection, human interferon a1b eye drops, and recombinant human interferon a1b spray. The company was founded by Yun De Hou and Yong Qing Cheng on September 24, 1992 and is headquartered in Beijing, China.	Direktor/Vorstandsmitglied	-